Luis Martínez
University of Seville
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Luis Martínez.
Clinical Infectious Diseases | 2013
Luis Eduardo López-Cortés; María Dolores del Toro; Juan Gálvez-Acebal; Elena Bereciartua-Bastarrica; María Carmen Fariñas; Mercedes Sanz-Franco; Clara Natera; Juan E. Corzo; José Manuel Lomas; Juan Pasquau; Alfonso del Arco; María Paz Martínez; Alberto Romero; Miguel A. Muniain; Marina de Cueto; Álvaro Pascual; Jesús Rodríguez-Baño; C. Velasco; Francisco J. Caballero; Miguel Montejo; Jorge Calvo; Marta Aller-Fernández; Luis Martínez Martínez; María Dolores Rojo; Victoria Manzano-Gamero
BACKGROUND Staphylococcus aureus bacteremia (SAB) is associated with significant morbidity and mortality. Several aspects of clinical management have been shown to have significant impact on prognosis. The objective of the study was to identify evidence-based quality-of-care indicators (QCIs) for the management of SAB, and to evaluate the impact of a QCI-based bundle on the management and prognosis of SAB. METHODS A systematic review of the literature to identify QCIs in the management of SAB was performed. Then, the impact of a bundle including selected QCIs was evaluated in a quasi-experimental study in 12 tertiary Spanish hospitals. The main and secondary outcome variables were adherence to QCIs and mortality. Specific structured individualized written recommendations on 6 selected evidence-based QCIs for the management of SAB were provided. RESULTS A total of 287 and 221 patients were included in the preintervention and intervention periods, respectively. After controlling for potential confounders, the intervention was independently associated with improved adherence to follow-up blood cultures (odds ratio [OR], 2.83; 95% confidence interval [CI], 1.78-4.49), early source control (OR, 4.56; 95% CI, 2.12-9.79), early intravenous cloxacillin for methicillin-susceptible isolates (OR, 1.79; 95% CI, 1.15-2.78), and appropriate duration of therapy (OR, 2.13; 95% CI, 1.24-3.64). The intervention was independently associated with a decrease in 14-day and 30-day mortality (OR, 0.47; 95% CI, .26-.85 and OR, 0.56; 95% CI, .34-.93, respectively). CONCLUSIONS A bundle orientated to improving adherence to evidence-based QCIs improved the management of patients with SAB and was associated with reduced mortality.
BMC Infectious Diseases | 2012
Galo Peralta; María Lamelo; Patricia Álvarez-García; María Velasco; Alberto Delgado; Juan Pablo Horcajada; María Milagro Montero; María Pía Roiz; María Carmen Fariñas; Juan Alonso; Luis Martínez Martínez; Alfonso Gutiérrez-Macías; Jose Angel Alava; Azucena Rodríguez; Ana Fleites; Vicente Navarro; Elia Sirvent; Jose Antonio Capdevila
BackgroundThe objective of this study is to analyze the factors that are associated with the adequacy of empirical antibiotic therapy and its impact in mortality in a large cohort of patients with extended-spectrum β-lactamase (ESBL) - producing Escherichia coli and Klebsiella spp. bacteremia.MethodsCases of ESBL producing Enterobacteriaceae (ESBL-E) bacteremia collected from 2003 through 2008 in 19 hospitals in Spain. Statistical analysis was performed using multivariate logistic regression.ResultsWe analyzed 387 cases ESBL-E bloodstream infections. The main sources of bacteremia were urinary tract (55.3%), biliary tract (12.7%), intra-abdominal (8.8%) and unknown origin (9.6%). Among all the 387 episodes, E. coli was isolated from blood cultures in 343 and in 45.71% the ESBL-E was multidrug resistant. Empirical antibiotic treatment was adequate in 48.8% of the cases and the in hospital mortality was 20.9%. In a multivariate analysis adequacy was a risk factor for death [adjusted OR (95% CI): 0.39 (0.31-0.97); P = 0.04], but not in patients without severe sepsis or shock. The class of antibiotic used empirically was not associated with prognosis in adequately treated patients.ConclusionESBL-E bacteremia has a relatively high mortality that is partly related with a low adequacy of empirical antibiotic treatment. In selected subgroups the relevance of the adequacy of empirical therapy is limited.
Surface & Coatings Technology | 2002
F.J. Pérez; D Duday; M.P. Hierro; C. Gómez; A Agüero; M.C Garcı́a; Rosa Muela; A Sanchez Pascual; Luis Martínez Martínez
Abstract The corrosion behavior of Al coated AISI 310S stainless steel by slurry and ion vapor deposition (IVD) was investigated as an electrolyte seal material in a mounted carbonate fuel cell (MCFC) at 650 °C. The results were compared with uncoated AISI 310S stainless steel and TA6V alloy. The characterization of the samples after exposure to the eutectic 62 mol.% Li 2 CO 3 –38 mol.% K 2 CO 3 mixture at 650 °C up to 1000 h has shown the presence of LiAlO 2 (coated samples), LiFeO 2 and LiCrO 2 (stainless steels), and Li 2 TiO 3 (TA6V) oxides at the scale–melt interface. The electrochemical impedance spectroscopy (EIS) technique has shown high values of polarization resistances for TA6V and lower values for coated steels. The uncoated AISI 310S stainless steel have shown the lowest polarization resistance. A mechanism for the corrosion of Al-coated stainless steels in molten carbonate is proposed taking into account thermodynamic simulations, X-ray diffraction (XRD), scanning electron microscopy (SEM) characterizations, and EIS results. This proposed mechanism confirms that a slurry aluminide coating is able to improve the stainless steel behavior in molten carbonate. However, the TA6V titanium alloy is the most resistant material in molten carbonate but the Al-coated stainless steels appear as the best lifetime-cost compromise.
Journal of Infection | 2015
Evelyn Shaw; Natividad Benito; Jesús Rodríguez-Baño; Belén Padilla; Vicente Pintado; Esther Calbo; MªAngeles Pallarés; Mónica Gozalo; Patricia Ruiz-Garbajosa; Juan Pablo Horcajada; J. Gómez; Emilia Cercenado; E. Bunshow; Carlos Sánchez-Carrillo; Mariona Xercavins; Montserrat Riera; Beatriz Mirelis; R. Gamallo; Luis Martínez Martínez; M.C. Fariñas; M. de Cueto; Álvaro Pascual
OBJECTIVE To determine risks factors associated with severe sepsis or septic shock (SS) at admission in patients with community-onset bacteraemic urinary tract infection (CO-BUTI) including the impact of multidrug-resistant (MDR) bacteria. METHODS We analysed a prospective cohort of all consecutive episodes of CO-BUTI requiring hospitalisation in 8 tertiary hospitals of Spain between October 2010 and June 2011. RESULTS Of an overall of 525 CO-BUTI episodes, 175 (33%) presented with SS at admission. MDR bacteria were isolated in 29% (51/175) of episodes with SS and in 33% (117/350) of those without SS (p = 0.32). The main MDR microorganism was Escherichia coli in both groups (25% and 28% respectively). Independent risk factors associated with SS at admission were: having fatal underlying conditions, McCabe score II/III (OR 1.90; 95%CI 1.23-2.92; p = 0.004), presence of an indwelling urethral catheter (OR 3.01; 95%CI 1.50-6.03; p = 0.002) and a history of urinary tract obstruction (OR 1.56; 95%CI 1.03-2.34; p = 0.03). After considering interactions, indwelling urethral catheters were a risk factor only for patients without fatal underlying conditions. CONCLUSIONS SS at hospital admission occurred in a third of CO-BUTI. Mainly host factors, and not the causative microorganisms or antimicrobial resistance patterns had an impact on the presence of SS.
Journal of Basic Microbiology | 2003
Felipe Fernández Cuenca; Álvaro Pascual; Luis Martínez Martínez; M. C. Conejo; Evelio J. Perea
Enfermedades Infecciosas Y Microbiologia Clinica | 2002
Fátima Beceiro; Juan Ramón Maestre; Victoria Buezas; Paloma Sánchez; Luis Martínez Martínez; Rafael Ortigueira
Enfermedades Infecciosas Y Microbiologia Clinica | 2000
Providencia Joyanes; Bruno Mazza; Luis Martínez Martínez; Guillermo López-López; Álvaro Pascual
Enfermedades Infecciosas Y Microbiologia Clinica | 2002
Álvaro Pascual; Benito Almirant; Luis Martínez Martínez; José M. Miró
Enfermedades Infecciosas Y Microbiologia Clinica | 2000
Felipe Fernández; Luis Martínez Martínez; Álvaro Pascual; Evelio J. Perea
Publicación científica biomédica: Cómo escribir y publicar un artículo de investigación, 2015, ISBN 978-84-9022-870-8, págs. 293-310 | 2015
Alvaro Pascual Hernández; Luis Martínez Martínez